Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2011-2012 seasonal trivalent inactivated influenza vaccine
- Development stage
- Phase 3
- Lead developer
- BIRMEX
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The 2011-2012 seasonal trivalent inactivated influenza vaccine is a biological preparation designed to provide active acquired immunity against three specific strains of the influenza virus: A/California/7/2009 (H1N1)pdm09-like, A/Perth/16/2009 (H3N2)-like, and B/Brisbane/60/2008-like. Developed for the 2011-2012 influenza season in the Northern Hemisphere, this specific formulation was evaluated by the Instituto Nacional de Salud Publica in Mexico for its safety and immunogenicity in pregnant women. It is an unadjuvanted, inactivated vaccine administered via intramuscular injection, containing 15 µg of hemagglutinin per strain to stimulate a protective immune response.
- Other names
- 2-Instituto Nacional de Salud Publica, Mexico-influenza2011-2012 Seasonal TIVVACINFL2011 vaccineVACINFL-2011 vaccineVACINFL 2011 vaccine
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on 2011-2012 seasonal trivalent inactivated influenza vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2011-2012 seasonal trivalent inactivated influenza vaccine.